What is Favipiravir? FDA Approves COVID Prevention Study in US Nursing Homes
Armand Balboni, MD, PhD, discusses progress toward FDA authorization and/or approval of favipiravir for COVID-19 as a prophylactic measure.
Armand Balboni, MD, PhD, discusses progress toward FDA authorization and/or approval of favipiravir for COVID-19 as a prophylactic measure.
The results were presented at the Society for Healthcare Epidemiology of America (SHEA) conference, highlighting this first documented case of C auris moving from an…
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
A study, presented at the Society for Healthcare Epidemiology of America (SHEA) conference, assesses laxative administration before CDI testing in Veteran Affairs (VA) hospitals and…
Hospitals grapple with the costly burden of healthcare-associated infections (HAIs), and artificial intelligence (AI) is emerging as a game-changer in revolutionizing infection prevention strategies.
A small study found physical health problems lingered 1 year after their hospital stay.
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Current progress of WHO’s strategies to enhance global health outcomes through improved diagnosis and treatment of viral hepatitis.
A small study found physical health problems lingered 1 year after their hospital stay.
Officials announce an end of Listeria traced to Rizo-López dairy products involving queso fresco and cotija.
Incidence of hospital-onset Clostridioides difficile infection differed between hospitals that implemented the CDC prevention strategies and those that did not, but not necessarily because of…